Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer

References

• Avramiotis S, Papadimitriou V, Hatzara E, et al. (2007). Lecithin organogels used as bioactive compounds carriers. A microdomain properties investigation. Langmuir 23:4438–47.
   PubMed Web of Science ®Google Scholar
• Ba W, Li Z, Wang L, et al. (2016). Optimization and evaluation of pluronic lecithin organogels as a transdermal delivery vehicle for sinomenine. Pharm Dev Technol 21:535–45.
   PubMed Web of Science ®Google Scholar
• Batist G, Sawyer M, Gabrail N, et al. (2008). A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC). JCO 26:4108.
   Web of Science ®Google Scholar
• Cai L, Xu G, Shi C, et al. (2015). Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: a synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials 37:456–468.
   PubMed Web of Science ®Google Scholar
• Chen AM, Zhang M, Wei D, et al. (2009). Co‐delivery of doxorubicin and Bcl‐2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug‐resistant cancer cells. Small 5:2673–2677.
   PubMed Web of Science ®Google Scholar
• Cheng Y, He C, Ding J, et al. (2013). Thermosensitive hydrogels based on polypeptides for localized and sustained delivery of anticancer drugs. Biomaterials 34:10338–10347.
   PubMed Web of Science ®Google Scholar
• Cho JK, Kuh HJ, Song SC. (2014). Injectable poly(organophosphazene) hydrogel system for effective paclitaxel and doxorubicin combination therapy. J Drug Target 22:761–7.
   PubMed Web of Science ®Google Scholar
• Cho YI, Park S, Jeong SY, Yoo HS. (2009). In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates. Eur J Pharm Biopharm 73:59–65.
   PubMed Web of Science ®Google Scholar
• Deconti RC, Toftness BR, Lange RC, Creasey WA. (1973). Clinical and pharmacological studies with cis-diamminedichloropl atinum(II). Cancer Res 33:1310–1315.
   PubMed Web of Science ®Google Scholar
• Desale SS, Cohen SM, Zhao Y, et al. (2013). Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J Control Release 171:339–48.
   PubMed Web of Science ®Google Scholar
• Desale SS, Soni KS, Romanova S, et al. (2015). Targeted delivery of platinum-taxane combination therapy in ovarian cancer. J Control Release 220:651–9.
   PubMed Web of Science ®Google Scholar
• Elstad NL, Fowers KD. (2009). OncoGel (ReGel/paclitaxel)–clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev 61:785–94.
   PubMed Web of Science ®Google Scholar
• Fan R, Tong A, Li X, et al. (2015). Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. Int J Nanomed 10:7291–7305.
   PubMed Web of Science ®Google Scholar
• Feldman EJ, Lancet JE, Kolitz JE, et al. (2011). First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia. JCO 29:979–85.
   PubMed Web of Science ®Google Scholar
• Gao K, Sun J, Liu K, et al. (2008). Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Industr Pharm 34:1227–1237.
   PubMed Web of Science ®Google Scholar
• Hasenstein JR, Shin H-C, Kasmerchak K, et al. (2012). Antitumor activity of triolimus: a novel multidrug-loaded micelle containing paclitaxel, rapamycin, and 17-AAG. Mol Cancer Ther 11:2233–2242.
   PubMed Web of Science ®Google Scholar
• Hu CM, Aryal S, Zhang L. (2010). Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv 1:323–34.
   PubMedGoogle Scholar
• Hu CM, Zhang L. (2012). Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharm 83:1104–11.
   PubMed Web of Science ®Google Scholar
• Jhan HJ, Liu JJ, Chen YC, et al. (2015). Novel injectable thermosensitive hydrogels for delivering hyaluronic acid-doxorubicin nanocomplexes to locally treat tumors. Nanomedicine 10:1263–74.
   PubMed Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. (2011). Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6:715–728.
   PubMed Web of Science ®Google Scholar
• Kim S, Nishimoto SK, Bumgardner JD, et al. (2010). A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 31:4157–66.
   PubMed Web of Science ®Google Scholar
• Klouda L, Mikos AG. (2008). Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68:34–45.
   PubMed Web of Science ®Google Scholar
• Kumar R, Katare OP. (2005). Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. AAPS Pharmscitech 6:298–310.
   PubMed Web of Science ®Google Scholar
• Lee JH, Nan A. (2012). Combination drug delivery approaches in metastatic breast cancer. J Drug Deliv 2012:1–17.
   Google Scholar
• Liu Y, Fang J, Kim Y-J, et al. (2014). Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity. Mol Pharm 11:1651–1661.
   PubMed Web of Science ®Google Scholar
• Luo J-W, Zhang T, Zhang Q, et al. (2016). A novel injectable phospholipid gel co-loaded with doxorubicin and bromotetrandrine for resistant breast cancer treatment by intratumoral injection. Colloids Surf B Biointerfaces 140:538–547.
   PubMed Web of Science ®Google Scholar
• Ma H, He C, Cheng Y, et al. (2015). Localized co-delivery of doxorubicin, cisplatin, and methotrexate by thermosensitive hydrogels for enhanced osteosarcoma treatment. ACS Appl Mater Interfaces 7:27040–8.
   PubMed Web of Science ®Google Scholar
• Parhi P, Mohanty C, Sahoo SK. (2012). Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today 17:1044–52.
   PubMed Web of Science ®Google Scholar
• Ringel I, Horwitz SB. (1991). Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83:288–291.
   PubMed Web of Science ®Google Scholar
• Ruiz M, Clares B, Morales M, Gallardo V. (2007). Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles. Pharm Dev Technol 12:637–644.
   PubMed Web of Science ®Google Scholar
• Shaikh IM, Tan KB, Chaudhury A, et al. (2013). Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft. J Control Release 172:852–861.
   PubMed Web of Science ®Google Scholar
• Shen W, Luan J, Cao L, et al. (2015). Thermogelling polymer-platinum(IV) conjugates for long-term delivery of cisplatin. Biomacromolecules 16:105–15.
   PubMed Web of Science ®Google Scholar
• Tardi P, Johnstone S, Harasym N, et al. (2009). In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. Leukemia Res 33:129–39.
   PubMed Web of Science ®Google Scholar
• Wang D, Lippard SJ. (2005). Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–20.
   PubMed Web of Science ®Google Scholar
• Willimann H-L, Luisi PL. (1991). Lecithin organogels as matrix for the transdermal transport of drugs. Biochem Biophys Res Commun 177:897–900.
   PubMed Web of Science ®Google Scholar
• Wu H, Jin H, Wang C, et al. (2017). Synergistic cisplatin/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery. ACS Appl Mater Interfaces 9:9426–9436.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zou X, Yang L, et al. (2014). Thermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancer. Colloids Surf B Biointerfaces 122:90–98.
   PubMed Web of Science ®Google Scholar
• Yin YM, Cui FD, Mu CF, et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 140:86–94.
   PubMed Web of Science ®Google Scholar